SENS Foundation granted tax-exempt status as 501(c)(3) public charity.

Posted by Sarah Marr on February 25, 2011 | Founders

SENS Foundation is pleased to announce that it has been granted tax-exempt status as a 501(c)(3) public charity, with an effective date of March 9, 2009. Donations to the Foundation are fully deductible as a charitable contribution.

Release: Internet Entrepreneur Jason Hope Pledges Half a Million Dollars to SENS Foundation

Posted by Sarah Marr on December 09, 2010 | Founders

The global scientific community is increasingly recognizing the role of rejuvenation biotechnologies in addressing age-related disease. This week, Arizona-based businessman Jason Hope announced a $500,000 donation to SENS Foundation, a California-based non-profit organization that works to develop, promote and ensure widespread access to rejuvenation biotechnologies which comprehensively address age-related disease.

Mike Kope's Address at "Breakthrough Philanthropy"

Posted by Mike Kope, CEO on December 08, 2010 | Founders

Last night, Peter Thiel hosted "Breakthrough Philanthropy", a dinner and presentation event showcasing eight non-profit organizations focused upon game-changing approaches to their fields. It was a wonderful opportunity for us to convey our message to a large group of entrepreneurs and philanthropists interested in the genuinely transformative. Our thanks to the Thiel Foundation, and the Seasteading Institute, for their efforts in creating that event.

Understanding SENS Foundation: mission, message and more.

Posted by Sarah Marr on October 27, 2010 | Founders

Over the last few days we’ve been working to change some of the content of our website, and this seems like a good time to contextualize those changes in a broader discussion of SENS Foundation: who we are, what we want to achieve, why we want to achieve it, and some things we need to do in order to get there. I’ll also address some of the misconceptions about us which I think exist.

Two Conferences You Shouldn't Miss

Posted by Aubrey de Grey, CSO on September 22, 2010 | Founders

This October, Hannover and Detroit will host two of the year's most interesting and wide-ranging scientific conferences in the biomedical field. I'll be chairing sessions at both events, focused on the application of regenerative medicine to aging and aging-related disease - a synergy we at SENS Foundation term rejuvenation biotechnology.

Research Prize: Breaking the Toughest AGE

Posted by Mike Kope, CEO on August 27, 2010 | Founders

On behalf of SENS Foundation, I'm pleased to announce the launch of a competitive research prize for "Breaking Advanced Glycation Endproduct Glucosepane, a Protein Cross-link" through Innocentive, a global leader in open innovation. This $20,000 Theoretical Research prize is designed to give us a clear enough roadmap towards the breakage of glucosepane that we can attract the further financial and scientific resources needed for a full-scale research and development project.